The Scleritis Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the Scleritis Market?
The scleritis market has experienced robust growth recently. The market size is projected to increase from $3.60 billion in 2024 to $3.94 billion in 2025, with a compound annual growth rate (CAGR) of 9.3%.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Scleritis Industry?
The Scleritis Global Market Report 2025 projects that by 2029, the scleritis market will reach a size of $5.54 billion. The market is also expected to grow at a compound annual growth rate (CAGR) of 8.9%.
Download Your Free Sample of the 2025 Scleritis Market Report and Uncover Key Trends Now!
What are the Key Growth Drivers Fueling the Scleritis Market?
The key drivers in the scleritis market are:
• Increasing occurrence of eye-related health conditions
• Growing public awareness about ocular health
• Expansion of healthcare expenditure globally
• Advancement and increasing research in the field of ophthalmology
Global Market Segmentation: Identifying Major Scleritis Industry Segments
The scleritis market covered in this report is segmented –
1) By Type: Anterior Scleritis, Posterior Scleritis, Other Types
2) By Treatment: Medication, Surgery, Other Treatment
3) By Distribution Channel: Direct Tender, Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channel
4) By End-Users: Hospitals, Specialty Clinics, Home Healthcare, Other End-Users
Subsegments:
1) By Anterior Scleritis: Non-Necrotizing Anterior Scleritis, Necrotizing Anterior Scleritis
2) By Posterior Scleritis: Diffuse Posterior Scleritis, Nodular Posterior Scleritis, Scleritis With Choroidal Involvement
3) By Other Types: Chronic Scleritis, Recurrent Scleritis, Infectious Scleritis
Pre-order the 2025 Scleritis Global Market Report for Fast Delivery & Comprehensive Insights!
What are the emerging Trends Shaping the Future of the Scleritis Market?
The key trends in the scleritis market are:
• The development of targeted biologic therapies is an emerging trend.
• There is an increasing trend towards the use of improved immunosuppressive drug formulations.
• The adoption of advanced imaging technologies and minimally invasive diagnostic tools is shaping the future of the market.
• Personalised medicine approaches, advanced drug delivery systems, and AI-driven diagnostic and treatment planning solutions are also trending.
Who Are the Top Competitors & Leading Players in the Scleritis Market?
Major players in the scleritis market are:
• Pfizer Inc.
• Johnson & Johnson
• F. Hoffmann-La Roche Ltd.
• Bayer AG
• Novartis AG
• Gilead Sciences Inc.
• Amgen Inc.
• Teva Pharmaceuticals USA Inc.
• Baxter International Inc.
• Boehringer Ingelheim
• Regeneron Pharmaceuticals Inc.
• Fresenius Kabi USA LLC
• Sun Pharmaceutical Industries Ltd.
• Perrigo Company
• Horizon Therapeutics plc
• Aurobindo Pharma Ltd.
• Hikma Pharmaceuticals PLC
• Amneal Pharmaceuticals LLC
• Mallinckrodt Pharmaceuticals
• Alvogen
• Accord Healthcare
• West-Ward Pharmaceuticals
• Jubilant Cadista Pharmaceuticals Inc.
• Mylan Pharmaceuticals Inc.
• Zydus Pharmaceuticals Inc.
Regional Dominance: Which Area Leads the Global Template Market?
North America was the largest region in the scleritis market in 2024
